TK1 and hepatocellular carcinoma: Therefore, further studies of TK1 may improve our understanding of HCC immunobiology and could help to break immune tolerance in HCC with poor immunogenicity, thus providing a theoretical basis for the development of anti-TK1 immunotherapy in this tumor type.